89 results
10-Q
2024 Q1
EX-10.1
FBRX
Forte Biosciences Inc
Quarterly report
13 May 24
4:15pm
10-K
2023 FY
EX-10.17
FBRX
Forte Biosciences Inc
Annual report
18 Mar 24
4:20pm
10-K
2023 FY
EX-10.16
FBRX
Forte Biosciences Inc
Annual report
18 Mar 24
4:20pm
8-K
EX-10.1
FBRX
Forte Biosciences Inc
20 Sep 23
Departure of Directors or Certain Officers
4:15pm
8-K
EX-10.2
FBRX
Forte Biosciences Inc
1 Aug 23
Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102
4:06pm
8-K
EX-10.1
uy30ze
1 Aug 23
Forte Biosciences, Inc. Announces $25 Million Financing and R&D Update for FB-102
4:06pm
8-K
EX-10.1
cfbqmul
31 Mar 22
Entry into a Material Definitive Agreement
8:57pm
8-K
EX-10.1
n3c4q00q0t15xuqqlo3
4 Sep 20
Audited Financial Statements
4:31pm
S-8
EX-10.2
e3wd55zz1fqzjm
11 Aug 20
Registration of securities for employees
5:19pm
S-8
EX-10.1
eywqaj m9
11 Aug 20
Registration of securities for employees
5:19pm
8-K
EX-10.1
eoq4b4szf1y8
15 Jun 20
Forte Biosciences, Inc. Announces Closing of Merger with Tocagen
5:21pm
S-4/A
EX-10.19
ykjw52s4f2c6g2t
27 Apr 20
Registration of securities issued in business combination transactions (amended)
6:27am